$EXEL
EXELIXIS, INC.

2024 Q3 Form 10-Q Financial Statement

#000093976724000119 Filed on August 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $539.5M $637.2M
YoY Change 14.33% 35.61%
Cost Of Revenue $17.33M $17.67M
YoY Change -7.7% -0.21%
Gross Profit $522.2M $619.5M
YoY Change 15.24% 37.02%
Gross Profit Margin 96.79% 97.23%
Selling, General & Admin $111.8M $132.0M
YoY Change -19.07% -6.85%
% of Gross Profit 21.41% 21.31%
Research & Development $222.6M $211.1M
YoY Change -33.08% -9.21%
% of Gross Profit 42.62% 34.08%
Depreciation & Amortization $7.454M $7.329M
YoY Change 18.32% 21.34%
% of Gross Profit 1.43% 1.18%
Operating Expenses $334.4M $343.2M
YoY Change -28.97% -8.32%
Operating Profit $136.1M $275.9M
YoY Change -873.9% 254.37%
Interest Expense $18.71M $17.26M
YoY Change -19.01% -23.44%
% of Operating Profit 13.75% 6.26%
Other Income/Expense, Net -$29.00K -$287.0K
YoY Change -110.03% 5640.0%
Pretax Income $154.8M $292.8M
YoY Change 2568.19% 191.72%
Income Tax $36.78M $66.73M
% Of Pretax Income 23.77% 22.79%
Net Earnings $118.0M $226.1M
YoY Change 11232.66% 178.54%
Net Earnings / Revenue 21.87% 35.49%
Basic Earnings Per Share $0.41 $0.78
Diluted Earnings Per Share $0.40 $0.77
COMMON SHARES
Basic Shares Outstanding 285.3M shares 291.3M shares
Diluted Shares Outstanding 291.5M shares 294.0M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.189B $1.002B
YoY Change 7.77% -20.9%
Cash & Equivalents $258.3M $198.5M
Short-Term Investments $930.8M $803.5M
Other Short-Term Assets $69.84M $58.25M
YoY Change 4.39% -6.44%
Inventory $21.01M $20.61M
Prepaid Expenses
Receivables $269.7M $396.6M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.550B $1.477B
YoY Change 7.37% -7.11%
LONG-TERM ASSETS
Property, Plant & Equipment $124.4M $130.2M
YoY Change 2.79% 13.22%
Goodwill $63.68M $63.68M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $523.4M $432.3M
YoY Change -35.52% -48.45%
Other Assets $698.8M $668.0M
YoY Change 30.24% 25.24%
Total Long-Term Assets $1.411B $1.296B
YoY Change -8.02% -16.51%
TOTAL ASSETS
Total Short-Term Assets $1.550B $1.477B
Total Long-Term Assets $1.411B $1.296B
Total Assets $2.960B $2.773B
YoY Change -0.56% -11.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $59.31M $28.68M
YoY Change 124.23% 10.32%
Accrued Expenses $176.8M $155.3M
YoY Change 3.1% 3.25%
Deferred Revenue $3.251M $3.443M
YoY Change -53.38% -49.38%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $394.3M $345.7M
YoY Change 4.65% 1.79%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $96.07M $109.7M
YoY Change 55.91% -60.11%
Total Long-Term Liabilities $96.07M $109.7M
YoY Change 55.91% -60.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $394.3M $345.7M
Total Long-Term Liabilities $96.07M $109.7M
Total Liabilities $684.9M $653.4M
YoY Change 8.83% 6.32%
SHAREHOLDERS EQUITY
Retained Earnings -$90.29M -$200.0M
YoY Change -28.37% -1887.7%
Common Stock $286.0K $285.0K
YoY Change -8.04% -10.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.275B $2.120B
YoY Change
Total Liabilities & Shareholders Equity $2.960B $2.773B
YoY Change -0.56% -11.75%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $118.0M $226.1M
YoY Change 11232.66% 178.54%
Depreciation, Depletion And Amortization $7.454M $7.329M
YoY Change 18.32% 21.34%
Cash From Operating Activities $271.3M $119.5M
YoY Change 131.12% -1.18%
INVESTING ACTIVITIES
Capital Expenditures $8.197M $6.570M
YoY Change -11.86% 10.66%
Acquisitions
YoY Change
Other Investing Activities -$209.0M $88.34M
YoY Change -574.89% -230.21%
Cash From Investing Activities -$217.1M $81.77M
YoY Change -725.78% -210.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.696M -262.4M
YoY Change -102.59% 110.29%
NET CHANGE
Cash From Operating Activities 271.3M 119.5M
Cash From Investing Activities -217.1M 81.77M
Cash From Financing Activities 5.696M -262.4M
Net Change In Cash 59.89M -61.10M
YoY Change -188.59% -21.26%
FREE CASH FLOW
Cash From Operating Activities $271.3M $119.5M
Capital Expenditures $8.197M $6.570M
Free Cash Flow $263.1M $113.0M
YoY Change 143.42% -1.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
728717000 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
391998000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
275874000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
77850000 usd
CY2024Q2 us-gaap Interest Income Other
InterestIncomeOther
17258000 usd
CY2023Q2 us-gaap Interest Income Other
InterestIncomeOther
22541000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-287000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000 usd
CY2024Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
292845000 usd
CY2023Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
100386000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
66729000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19208000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
226116000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
81178000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
289216000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
324205000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
293974000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
327305000 shares
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
226116000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
81178000 usd
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
1512000 usd
CY2024Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
55000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
226171000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
76030000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.88
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
294986000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
324312000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
299752000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
326792000 shares
us-gaap Net Income Loss
NetIncomeLoss
263433000 usd
CY2024Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-17000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
416000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
5000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1399000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
84000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
262034000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
121290000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2128008000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
226116000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
55000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14659000 usd
CY2024Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
13015000 usd
CY2024Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
261684000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25595000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
2119734000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2555136000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
81178000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5148000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
10247000 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
10822000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24900000 usd
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
361304000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1253000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
443240000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
5323000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
862537000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
6576000 usd
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
803540000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
732308000 usd
CY2024Q2 us-gaap Long Term Investments
LongTermInvestments
432305000 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
302793000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
302793000 shares
CY2024Q2 us-gaap Restructuring Charges
RestructuringCharges
475000 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
0 usd
us-gaap Restructuring Charges
RestructuringCharges
33310000 usd
us-gaap Restructuring Charges
RestructuringCharges
0 usd
us-gaap Costs And Expenses
CostsAndExpenses
757068000 usd
us-gaap Costs And Expenses
CostsAndExpenses
771956000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
305336000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
106680000 usd
us-gaap Interest Income Other
InterestIncomeOther
37152000 usd
us-gaap Interest Income Other
InterestIncomeOther
42043000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-376000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-59000 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
342112000 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
148664000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
78679000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27458000 usd
us-gaap Net Income Loss
NetIncomeLoss
263433000 usd
us-gaap Net Income Loss
NetIncomeLoss
121206000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.89
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.37
us-gaap Net Income Loss
NetIncomeLoss
121206000 usd
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5148000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
127814000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25161000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2527938000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2263912000 usd
us-gaap Net Income Loss
NetIncomeLoss
263433000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1399000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
23097000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
20009000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
454225000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
44925000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
2119734000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2488427000 usd
us-gaap Net Income Loss
NetIncomeLoss
121206000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
84000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
17327000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
13345000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
127814000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
42053000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2527938000 usd
us-gaap Net Income Loss
NetIncomeLoss
263433000 usd
us-gaap Net Income Loss
NetIncomeLoss
121206000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13707000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12895000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
44467000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
41561000 usd
exel Noncash Lease Expense
NoncashLeaseExpense
13943000 usd
exel Noncash Lease Expense
NoncashLeaseExpense
13980000 usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
20250000 usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
37500000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-7924000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
8176000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
159217000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18317000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3075000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12815000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-33660000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-8548000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2350000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3272000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-50522000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5732000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
188370000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
205386000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16261000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17961000 usd
us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
26750000 usd
us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
38000000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
247154000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
641328000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
483730000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
573912000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
193565000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-123377000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
449694000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
124239000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
23238000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
17422000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
20014000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
13389000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-446470000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-120206000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-64535000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-38197000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
262994000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
502677000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
198459000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
464480000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
15313000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
13584000 usd
us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a 52- or 53-week fiscal year policy that generally ends on the Friday closest to December 31. Fiscal year 2024, which is a 53-week fiscal year, will end on January 3, 2025 and fiscal year 2023, which was a 52-week fiscal year, ended on December 29, 2023. For convenience, references in this report as of and for the fiscal periods ended June 28, 2024, and as of and for the fiscal years ending January 3, 2025 and ended December 29, 2023 are indicated as being as of and for the periods ended June 30, 2024, and the years ending December 31, 2024 and ended December 31, 2023, respectively.</span></div>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the accompanying Condensed Consolidated Financial Statements conforms to accounting principles generally accepted in the U.S., which requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses and related disclosures. On an ongoing basis, we evaluate our significant estimates. We base our estimates on historical experience and on various other market-specific and other relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from those estimates.</span></div>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts in the accompanying Condensed Consolidated Financial Statements have been reclassified to conform to the current period presentation. Such reclassifications did not impact previously reported total revenues, income from operations, net income, total assets, total liabilities or total stockholders’ equity.</span></div>
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
637178000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
469848000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1062404000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
878636000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
637178000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
469848000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1062404000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
878636000 usd
CY2023Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
84840000 usd
exel Valuation Allowances And Reserves Additions For Sales In Current Period
ValuationAllowancesAndReservesAdditionsForSalesInCurrentPeriod
355264000 usd
exel Valuation Allowances And Reserves Additions For Sales In Prior Period
ValuationAllowancesAndReservesAdditionsForSalesInPriorPeriod
-3292000 usd
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
345310000 usd
CY2024Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
91502000 usd
CY2024Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1469000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1321000 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3443000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5406000 usd
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
4420000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
5524000 usd
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
7863000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
10930000 usd
exel Contract With Customer Liability Including New Contract Revenue Recognized
ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized
3000000 usd
exel Contract With Customer Liability Including New Contract Revenue Recognized
ContractWithCustomerLiabilityIncludingNewContractRevenueRecognized
3600000 usd
CY2024Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1283442000 usd
CY2024Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
363000 usd
CY2024Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
6678000 usd
CY2024Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1277127000 usd
CY2024Q2 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Amortized Cost Basis
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
1440619000 usd
CY2024Q2 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
363000 usd
CY2024Q2 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
6678000 usd
CY2024Q2 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecurities
1434304000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1501923000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2076000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
6576000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1497423000 usd
CY2023Q4 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Amortized Cost Basis
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
1728519000 usd
CY2023Q4 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2076000 usd
CY2023Q4 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
6576000 usd
CY2023Q4 exel Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Available For Sale Debt Securities
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndAvailableForSaleDebtSecurities
1724019000 usd
CY2024Q2 us-gaap Interest Receivable
InterestReceivable
11100000 usd
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
13100000 usd
CY2024Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
459857000 usd
CY2024Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1711000 usd
CY2024Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
490916000 usd
CY2024Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
4967000 usd
CY2024Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
950773000 usd
CY2024Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
6678000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
419297000 usd
CY2024Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
286 investment
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
230 investment
CY2024Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2024Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
844822000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
768706000 usd
CY2024Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
432305000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
728717000 usd
CY2024Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1277127000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1497423000 usd
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
2912000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
7313000 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
58468000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
59422000 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
12319000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
9581000 usd
CY2024Q2 us-gaap Inventory Gross
InventoryGross
73699000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
76316000 usd
CY2024Q2 us-gaap Inventory Gross
InventoryGross
73699000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
76316000 usd
exel Share Based Compensation Arrangement By Share Based Payment Award Reduction In Share Reserve Due To Stock Option Or Stock Appreciation Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardReductionInShareReserveDueToStockOptionOrStockAppreciationAward
1 shares
exel Share Based Compensation Arrangement By Share Based Payment Award Reduction In Share Reserve Due To Other Awards
ShareBasedCompensationArrangementByShareBasedPaymentAwardReductionInShareReserveDueToOtherAwards
2 shares
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
25354000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
44467000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
41561000 usd
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
25354000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24900000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
44467000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
41561000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
100000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
22.46
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.79
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7200000 shares
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
6800000 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.228
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.230
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.191
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.185
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
226116000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
81178000 usd
us-gaap Net Income Loss
NetIncomeLoss
263433000 usd
us-gaap Net Income Loss
NetIncomeLoss
121206000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
289216000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
324205000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
294986000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
324312000 shares
CY2024Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4758000 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3100000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4766000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2480000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
293974000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
327305000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
299752000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
326792000 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.89
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.37
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.88
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
CY2021Q2 exel Loss Contingency Number Of Lawsuits Consolidated
LossContingencyNumberOfLawsuitsConsolidated
2 lawsuit
CY2022Q3 exel Loss Contingency Number Of Lawsuits Consolidated
LossContingencyNumberOfLawsuitsConsolidated
2 lawsuit
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000939767-24-000119-index-headers.html Edgar Link pending
0000939767-24-000119-index.html Edgar Link pending
0000939767-24-000119.txt Edgar Link pending
0000939767-24-000119-xbrl.zip Edgar Link pending
exel-20240628.htm Edgar Link pending
exel-20240628.xsd Edgar Link pending
exel-20240628_g1.jpg Edgar Link pending
exel20240630exhibit31110-q.htm Edgar Link pending
exel20240630exhibit31210-q.htm Edgar Link pending
exel20240630exhibit32110-q.htm Edgar Link pending
exelixisinc2000employeesto.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
exel-20240628_def.xml Edgar Link unprocessable
exel-20240628_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
exel-20240628_pre.xml Edgar Link unprocessable
exel-20240628_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
exel-20240628_cal.xml Edgar Link unprocessable